From: Sleep quality among psoriasis patients: excluding the immunosuppressive therapy effect
 | Correlation coefficient | P value | N |
---|---|---|---|
BDI | |||
 PSQI-global | 0.201 | 0.045 | 100 |
 Subjective sleep quality | 0.277 | 0.005 | 100 |
 Sleep latency | 0.151 | 0.135 | 100 |
 Sleep duration | -0.012 | 0.906 | 100 |
 Habitual sleep efficiency | -0.102 | 0.313 | 100 |
 Sleep disturbance | 0.151 | 0.134 | 100 |
 Use of sleeping medication | 0.181 | 0.071 | 100 |
 Daytime dysfunction | 0.185 | 0.066 | 100 |
 ISI | 0.223 | 0.026 | 100 |
Taylor Manifest Anxiety Scale | |||
 PSQI-global score | 0.286 | 0.004 | 100 |
 Subjective sleep quality | 0.262 | 0.008 | 100 |
 Sleep latency | 0.259 | 0.009 | 100 |
 Sleep duration | 0.096 | 0.340 | 100 |
 Habitual sleep efficiency | -0.041 | 0.683 | 100 |
 Sleep disturbance | 0.237 | 0.017 | 100 |
 Use of sleeping medication | 0.225 | 0.024 | 100 |
 Daytime dysfunction | 0.207 | 0.039 | 100 |
 ISI | 0.314 | 0.001 | 100 |